Medical treatment to lower uric acid levels
Patent 6162831 Issued on December 19, 2000. Estimated Expiration Date: 
March 25, 2019. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
March 25, 2019. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesUse of N,N-dimethyl-1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutylamine Patent #: 4939175 InventorsAssigneeApplicationNo. 269339 filed on 03/25/1999US Classes:514/646Benzene ring containingExaminersPrimary: Jordan, KimberlyAttorney, Agent or FirmForeign Patent References
International ClassA61K 031/135Foreign Application Priority Data1996-09-25 GBAbstractA compound of formula I ##STR1## or a pharmaceutically acceptable salt thereof in which R1 and R2 are independently H or methyl (for example N,N-dimethyl-1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl amine hydrochloride optionally in the form of its monohydrate) is used for lowering the uric acid level in humans, for example in humans suffering from or at risk of developing gout, hyperuricaemia or coronary heart disease.Field of SearchBenzene ring containing | |
